APA (7th ed.) Citation

S, M., G, S., A, B. C., M, A. A., I, H., R, H., . . . EB, J. (2026). Determinants of metabolic dysfunction associated steatotic liver disease and liver fibrosis in patients with type 2 diabetes mellitus: A cross-sectional study. Frontiers in medicine, 13, 1863576. https://doi.org/10.3389/fmed.2026.1863576

Chicago Style (17th ed.) Citation

S, Mrabet, et al. "Determinants of Metabolic Dysfunction Associated Steatotic Liver Disease and Liver Fibrosis in Patients with Type 2 Diabetes Mellitus: A Cross-sectional Study." Frontiers in Medicine 13 (2026): 1863576. https://doi.org/10.3389/fmed.2026.1863576.

MLA (9th ed.) Citation

S, Mrabet, et al. "Determinants of Metabolic Dysfunction Associated Steatotic Liver Disease and Liver Fibrosis in Patients with Type 2 Diabetes Mellitus: A Cross-sectional Study." Frontiers in Medicine, vol. 13, 2026, p. 1863576, https://doi.org/10.3389/fmed.2026.1863576.